Dhatri Lauha in the management of iron deficiency anemia: A prospective open-label single-arm multi-center trial

Background: The burden of iron-deficiency anemia (IDA) remains persistently high in India due to the poor tolerability of oral iron supplementation. Therefore, more focus is required to explore traditional medicine for safe and effective options for managing IDA. Aim: To assess the clinical safety and efficacy of Dhatri Lauha in patients with IDA. Materials and methods: An open-label, prospective, single-arm, multi-center trial was conducted at 12 centers with a sample size of 40 participants per study site. Patients with IDA aged 18-60 years with hemoglobin levels in the range of 6-10gm/dl, mean corpuscular volume (MCV) <80 fl, mean corpuscular hemoglobin concentration (MCHC) <34 μg/dl, serum ferritin <30 μg/dl and serum iron <50 μg/dl were included in the study. Dhatri Lauha 500 mg capsule was administered twice daily with lukewarm water after meals for 45 days. The primary outcome measure was the change in hemoglobin (Hb%) level from baseline to day 45. Secondary outcome measures included the change in MCV, MCHC, serum iron and ferritin levels, incidence of adverse events, and change in safety parameters (liver and kidney function tests). The mean (statistical) change in outcome measures from baseline to day 45 was compared using a paired sample t-test. Results: Out of 458 participants enrolled in the study, 400 contributed to the final analysis. A significant difference was observed in the outcome parameters such as Hb%, MCV, MCHC, serum ferritin, and serum iron levels (P < 0.001) after 45 days of treatment. Mean Hb% changed from 8.46 ± 1.14 g/dl at baseline to 9.18 ± 1.61 g/dl on day 45 (P < 0.001). LFT and KFT were within the normal limits after the study period. No participant withdrew from the study due to adverse events. Conclusions:Dhatri Lauha is a safe intervention and can be expected to improve hemoglobin levels, red blood cell parameters, and iron stores in patients with IDA. Future RCTs with a larger sample size, standard care as control and a longer follow-up may produce more accurate and reliable results.

[1]  M. Muckenthaler,et al.  Iron deficiency , 2020, The Lancet.

[2]  W. Gardner,et al.  Global, Regional, and National Prevalence of Anemia and Its Causes in 204 Countries and Territories, 1990–2019 , 2020, Current Developments in Nutrition.

[3]  Amany El-Mleeh,et al.  Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae) , 2020, Biomolecules.

[4]  Koji Suzuki,et al.  Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study , 2019, Contemporary clinical trials communications.

[5]  R. Prasanth.  Prevalence of Anemia in both Developing and Developed Countries around the World , 2017 .

[6]  Harbans Singh,et al.  Clinical Efficacy and Safety of Navayasa Churna in the Management of Iron Deficiency Anemia , 2017 .

[7]  R. Singhal,et al.  Clinical Efficacy and Safety of Punarnavadi Mandura and Dadimadi Ghrita in the Management of Iron Deficiency Anemia: A Prospective Open-label Multicenter Study , 2017 .

[8]  Md. Mizanur Rahman,et al.  Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. , 2016, The American journal of clinical nutrition.

[9]  D. Richardson,et al.  The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption! , 2014, Free radical biology & medicine.

[10]  Anuradha Roy,et al.  Dhatrilauha: Right choice for iron deficiency anemia in pregnancy , 2014, Ayu.

[11]  Kaushal Kumar,et al.  Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) – validation of the Ayurvedic pharmacology through experimental and clinical studies , 2010, International journal of Ayurveda research.

[12]  B. Ravishankar,et al.  Toxicity and recovery studies of two ayurvedic preparations of iron. , 2009, Indian journal of experimental biology.

[13]  M. Majeed,et al.  Ascorbic acid and tannins from Emblica officinalis Gaertn. Fruits--a revisit. , 2009, Journal of agricultural and food chemistry.

[14]  D. Sharma,et al.  Scientific evaluation of some Ayurvedic preparations for correction of iron deficiency and anemia , 2007, Indian Journal of Clinical Biochemistry.

[15]  B. Ravishankar,et al.  Haematinic evaluation of Lauha bhasma and Mandura bhasma on HgCl 2 -induced anemia in rats , 2007 .

[16]  Richard F Hurrell,et al.  Nutritional iron deficiency , 2007, The Lancet.

[17]  Amanda J. Patterson,et al.  Iron deficiency, general health and fatigue: Results from the Australian Longitudinal Study on Women's Health , 2004, Quality of Life Research.

[18]  Iron deficiency--United States, 1999-2000. , 2002, MMWR. Morbidity and mortality weekly report.

[19]  O. Jolobe.  Guidelines for the management of iron deficiency anaemia , 2001, Gut.

[20]  R. Kuttan,et al.  Hepatoprotective activity of Emblica officinalis and Chyavanaprash. , 2000, Journal of ethnopharmacology.

[21]  B. Shaw,et al.  Chemical and pharmacological evaluation of different ayurvedic preparations of iron. , 1999, Journal of ethnopharmacology.

[22]  F. Firkin,et al.  Diagnostic Tests: Interpretation of biochemical tests for iron deficiency: diagnostic difficulties related to limitations of individual tests , 1997 .